Insmed | INSM - Net Income

Stock Price
150.99
Daily Change
-7.63 -4.81%
Monthly
-5.47%
Yearly
93.33%
Q1 Forecast
159.80

Insmed reported $-328.48M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
BioMarin Pharmaceutical USD -46.57M 15.83M Dec/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
DBV Technologies USD -33.16M 8.71M Sep/2025
Gilead Sciences USD 2.18B 869M Dec/2025
Heron Therapeutics USD -4.85M 4.39M Sep/2024
Insmed USD -328.48M 41.54M Dec/2025
Novartis USD 3.93B 113M Sep/2025
Regeneron Pharmaceuticals USD 844.6M 615.4M Dec/2025
Sarepta Therapeutics USD -179.95M 376.84M Sep/2025
Ultragenyx Pharmaceutical USD -129M 51.41M Dec/2025
Vertex Pharmaceuticals USD 1.19B 108.2M Dec/2025